| Literature DB >> 32243877 |
Christopher D Codispoti1, Sindhura Bandi1, James N Moy1, Mahboobeh Mahdavinia2.
Abstract
Entities:
Keywords: COVID-19; Virtual; allergy division; pandemic; training program
Mesh:
Year: 2020 PMID: 32243877 PMCID: PMC7201123 DOI: 10.1016/j.jaci.2020.03.018
Source DB: PubMed Journal: J Allergy Clin Immunol ISSN: 0091-6749 Impact factor: 10.793
Challenges and solutions in the urban academic allergy and immunology division in response to the COVID-19 pandemic
| Domains | Challenges | Solutions |
|---|---|---|
| Clinical | Social distancing (including reducing exposure in outpatient clinic and reducing need to round on inpatient consults with large team of fellows, residents, and students) | Converted all nonurgent in-person clinic visits to virtual (with video) or telephone visit All inpatient consults triaged for need for physical examination and risk of exposure to coronavirus; physical examination was not done if unnecessary. Discussion rounds were done virtually. Group rounds at patient rooms were avoided |
New virtual/telephone visit model | Rapid training of faculty and fellows on virtual/telephone visits | |
Increased telephone calls from patients concerned about possible COVID-19 | Nurses and fellows created phone call pools through a new triaged algorithm Faculty volunteered at special COVID-19 virtual visits at hospital level | |
Staffing and nursing shortage due to surge | Stopped all visits at central clinic Moved any urgent visit to 1 satellite location | |
Need for coronavirus-specific patient communication (eg, letters, work-from-home excuse, coronavirus symptoms, and risk stratification) | Standardized letters describing symptoms and when patients should call the COVID-19 hotline Generated COVID-19–specific letters | |
Biologic medications administration | Except omalizumab and few cases with disabilities, all other biologics were given at home. Moved all biological injections to 1 satellite location | |
Allergen immunotherapy (IT) | Halted all IT in accordance with AAAAI guidelines for 4 wk Created IT restart plans for interested individuals, with lowest possible frequency. Plans were discussed with patients over the phone | |
| Educational | Minimizing fellow exposure | Converted all educational meetings to Web-based meetings |
Staying current on COVID-19 literature | Expanded journal club and staff meetings Expanded case conference | |
Added complexity of fellows schedule in response to increased educational activities and redeployment | Shared calendar | |
Anticipating future COVID-19 challenges | Frequent discussions with program directors of Allergy/Immunology | |
| Research | Patient recruitment | Temporary suspension of all research recruitments Efforts were focused on completing information and chart reviews Expedited IRB amendments to switch consenting and follow-up visits to virtual and Web-based questionnaires |
Basic science research | Temporary halt of previous experiments Research lab members who were interested got involved in new studies related to COVID-19 experiments by other labs or volunteered in the clinical laboratory | |
| Hospital and community | Need for volunteers on the COVID-19 hotline Increased need for inpatient coverage for COVID-19 surge | Faculty volunteered to screen concerned patients for COVID-19 Nurses volunteers in various COVID-19 testing areas All providers were added to hospital surge lists for COVID-19 |
AAAAI, American Academy of Allergy, Asthma & Immunology; IRB, institutional review board; lab, laboratory.